How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG? - Charalabos-Markos Dintsios; Nadja Chernyak (Applied Health Economics and Health Policy, 2021)
Keywords: 610; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Health Administration; Public Health